Braun, Mathias,Busacca, Carl Alan,Chen, Feng-Jing,Gump, Edwin Louis,Majeska, Jenness B.,Pennino, Scott,Qiu, Fenghe,Villagra, Maria Fernanda
申请号：
AU2013208024
公开号：
AU2013208024A1
申请日:
2013.01.10
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
Described are various methods for stabilizing pharmaceutical formulations of a specific Hepatitis C Viral (HCV) inhibitor against the formation of a particular genotoxic degradation product. Such methods include temperature control, moisture control, excipient control, capsule shell control, basification and a reconstitution approach.
